Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Feb-24 7:36 PM View:  | Cero Therapeutics Holdings,... (CERO) | 14-Feb-24 | Acquisition (other) | 125,000 | -- | -- | 100% 0 to 125.0K | |
| 16-Feb-24 7:36 PM View: | Cero Therapeutics Holdings,... (CERO) | 14-Feb-24 | Acquisition (other) | 248,735 | -- | -- | 199% 125.0K to 373.74K | |
| 10-Nov-20 7:39 PM View: | Clovis Oncology, Inc. (CLVS) | 09-Nov-20 | Option Exercise | 6,896 | $3.08 | $21,239.70 | 4% 153.29K to 160.19K | |
| 22-Aug-19 4:15 PM View: | Clovis Oncology, Inc. (CLVS) | 20-Aug-19 | Option Exercise | 25,862 | $0.29 | $7,499.98 | 20% 127.43K to 153.29K | |
| 24-Jun-19 4:44 PM View: | Atreca, Inc. (BCEL) | 24-Jun-19 | Conversion | 8,791 | -- | -- | 22% 40.86K to 49.65K | |
| 28-Jun-17 6:53 PM View: | Clovis Oncology, Inc. (CLVS) | 26-Jun-17 | Acquisition (other) | 5,210 | -- | -- | 26% 20.37K to 25.58K | |
| 24-May-16 5:05 PM View: | Phaserx, Inc. (PZRX) | 23-May-16 | Purchase | 600,000 | $5.00 | $3,000,000.00 | 37% 1.6M to 2.2M | |
| 24-May-16 5:07 PM View: | Phaserx, Inc. (PZRX) | 23-May-16 | Purchase Duplicate | 600,000 | $5.00 | $3,000,000.00 | 37% 1.6M to 2.2M | |
| 24-May-16 5:05 PM View: | Phaserx, Inc. (PZRX) | 23-May-16 | Sale | 258,044 | $0.01 | $2,580.44 | (12%) 2.2M to 1.94M | |
| 24-May-16 5:07 PM View: | Phaserx, Inc. (PZRX) | 23-May-16 | Sale Duplicate | 258,044 | $0.01 | $2,580.44 | (12%) 2.2M to 1.94M | |
| 18-May-15 8:29 PM View: | Clovis Oncology, Inc. (CLVS) | 14-May-15 | Acquisition (other) | 98,291 | -- | -- | 12% 828.19K to 926.48K | |
| 18-May-15 8:29 PM View: | Clovis Oncology, Inc. (CLVS) | 14-May-15 | Disposition (other) | 498,696 | -- | -- | (54%) 926.48K to 427.78K | |
| 12-May-15 6:37 PM View: | Opgen Inc (OPGN) | 08-May-15 | Conversion | 2,068,290 | -- | -- | 2849% 72.59K to 2.14M | |
| 12-May-15 6:37 PM View: | Opgen Inc (OPGN) | 08-May-15 | Purchase | 413,332 | $6.00 | $2,479,990.00 | 19% 2.14M to 2.55M | |
| 31-Jul-14 5:45 PM View: | Immune Design Corp. (IMDZ) | 29-Jul-14 | Conversion Duplicate | 2,183,210 | -- | -- | 100% 0 to 2.18M | |
| 31-Jul-14 5:45 PM View: | Immune Design Corp. (IMDZ) | 29-Jul-14 | Purchase Duplicate | 233,333 | $12.00 | $2,800,000.00 | 11% 2.18M to 2.42M | |
| 31-Jul-14 5:45 PM View: | Immune Design Corp. (IMDZ) | 29-Jul-14 | Sale Duplicate | 208,334 | $12.00 | $2,500,010.00 | (9%) 2.42M to 2.21M | |
| 31-Mar-14 9:00 PM View: | Clovis Oncology, Inc. (CLVS) | 27-Mar-14 | Acquisition (other) | 12,213 | -- | -- | 1% 815.98K to 828.19K | |
| 21-Mar-14 1:29 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 5,007,070 | $14.00 | $70,099,000.00 | (100%) 5.01M to 0 | < 1% |
| 21-Feb-14 5:13 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Payment of Exercise | 389,295 | $14.00 | $5,450,130.00 | (7%) 5.4M to 5.01M | < 1% |
| 21-Feb-14 5:13 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 12-Feb-14 | Option Exercise | 695,168 | $7.84 | $5,450,120.00 | 15% 4.7M to 5.4M | |
| 04-Nov-13 8:13 PM View: | Veracyte, Inc. (VCYT) | 04-Nov-13 | Conversion | 3,616,220 | -- | -- | 100% 0 to 3.62M | |
| 24-Sep-13 7:36 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 23-Sep-13 | Conversion | 1,015,230 | -- | -- | 100% 0 to 1.02M | |
| 24-Sep-13 7:36 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 23-Sep-13 | Purchase | 76,923 | $13.00 | $999,999.00 | 8% 1.02M to 1.09M | |
| 05-Jun-13 5:30 PM View: | Clovis Oncology, Inc. (CLVS) | 03-Jun-13 | Grant | 1,142 | -- | -- | 100% 0 to 1.14K | |
| 17-Nov-11 7:36 PM View: | Clovis Oncology, Inc. (CLVS) | 16-Nov-11 | Acquisition (other) | 45,171 | -- | -- | 3% 1.51M to 1.55M | |
| 17-Nov-11 7:36 PM View: | Clovis Oncology, Inc. (CLVS) | 16-Nov-11 | Purchase Duplicate | 665,488 | -- | -- | 43% 1.55M to 2.22M | |
| 10-Aug-10 3:11 PM View: | Trius Therapeutics Inc (TSRX) | 06-Aug-10 | Conversion Duplicate | 2,321,310 | $1.40 | $3,260,890.00 | 60% 3.9M to 6.22M | |
| 10-Aug-10 3:11 PM View: | Trius Therapeutics Inc (TSRX) | 06-Aug-10 | Purchase Duplicate | 914,529 | $5.00 | $4,572,640.00 | 15% 6.22M to 7.13M | |
| 21-Sep-09 2:35 PM View: | Helicos BioSciences Corpora... (HLCS.PK) | 18-Sep-09 | Market Purchase | 242,931 | $2.57 | $625,013.00 | 2% 10.47M to 10.71M | (96%) |
| 20-Feb-09 4:41 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 18-Feb-09 | Grant | 1,390,340 | $7.13 | $9,913,100.00 | 42% 3.31M to 4.7M | 4% |
| 29-Dec-08 4:03 PM View: | Helicos BioSciences Corpora... (HLCS.PK) | 23-Dec-08 | Private Purchase Duplicate | 8,620,690 | -- | -- | 404% 2.14M to 10.76M | |
| 17-Mar-08 4:56 PM View: | Pharmion Corp (PHRM) | 07-Mar-08 | Disposition | 15,201 | -- | -- | (100%) 15.2K to 0 | |
| 22-Feb-08 5:13 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 20-Feb-08 | Grant | 1,310,860 | $5.34 | $7,000,000.00 | 66% 2.0M to 3.31M | 39% |
| 01-Jun-07 4:21 PM View: | Helicos BioSciences Corpora... (HLCS.PK) | 30-May-07 | Conversion | 2,024,160 | -- | -- | (103%) (-1.97M) to 54.97K | |
| 01-Jun-07 4:21 PM View: | Helicos BioSciences Corpora... (HLCS.PK) | 30-May-07 | Market Purchase | 111,111 | $9.00 | $999,999.00 | 202% 54.97K to 166.08K | (99%) |
| 01-Nov-06 2:41 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 30-Oct-06 | Conversion | 2,000,000 | -- | -- | 100% 0 to 2.0M | |
| 24-Feb-05 7:54 PM View: | Pharmion Corp (PHRM) | 23-Feb-05 | Acquisition (other) | 6,622 | -- | -- | 1% 477.68K to 484.3K | |
| 24-Feb-05 7:54 PM View: | Pharmion Corp (PHRM) | 23-Feb-05 | Disposition (other) | 469,097 | -- | -- | (97%) 484.3K to 15.2K | |
| 14-Jan-05 3:34 PM View: | Xenogen Corp (XGEN) | 13-Jan-05 | Disposition | 2,381 | -- | -- | (42%) 5.71K to 3.33K | |
| 28-Oct-04 10:00 PM View: | Pharmion Corp (PHRM) | 27-Oct-04 | Acquisition (other) | 7,192 | -- | -- | < 1% 939.4K to 946.6K | |
| 28-Oct-04 10:00 PM View: | Pharmion Corp (PHRM) | 27-Oct-04 | Disposition (other) | 469,099 | -- | -- | (50%) 946.6K to 477.5K | |
| 21-Jul-04 8:10 PM View: | Xenogen Corp (XGEN) | 21-Jul-04 | Conversion | 952,462 | -- | -- | 16666% 5.71K to 958.18K | |
| 21-Jul-04 8:10 PM View: | Xenogen Corp (XGEN) | 19-Jul-04 | Grant Duplicate | 5,715 | -- | -- | 100% 0 to 5.71K | |
| 27-May-04 9:31 PM View: | Pharmion Corp (PHRM) | 25-May-04 | Disposition (other) | -- | -- | -- | 0% 942.2K | |
| 27-May-04 8:08 PM View: | Pharmion Corp (PHRM) | 25-May-04 | Market Sale | 34,100 | $36.95 | $1,259,950.00 | (3%) 975.09K to 940.99K | (96%) |
| 27-May-04 9:12 PM View: | Pharmion Corp (PHRM) | 25-May-04 | Market Sale | 63,100 | $36.05 | $2,274,720.00 | (6%) 1.04M to 975.09K | (101%) |
| 27-May-04 9:31 PM View: | Pharmion Corp (PHRM) | 25-May-04 | Market Sale | 2,800 | $37.34 | $104,544.00 | (< 1%) 942.2K to 939.4K | (94%) |
| 27-May-04 6:01 AM View: | Pharmion Corp (PHRM) | 24-May-04 | Market Sale | 97,500 | $38.21 | $3,725,110.00 | (9%) 1.14M to 1.04M | (90%) |
| 27-May-04 6:05 AM View: | Pharmion Corp (PHRM) | 24-May-04 | Market Sale | 2,500 | $38.67 | $96,670.00 | (< 1%) 1.04M to 1.04M | (88%) |